BRIDGEWAY CAPITAL MANAGEMENT, LLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 79 filers reported holding HARVARD BIOSCIENCE INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$853,120
-21.7%
198,4000.0%0.02%
-19.2%
Q2 2023$1,089,216
+30.7%
198,4000.0%0.03%
+18.2%
Q1 2023$833,280
+34.7%
198,400
-11.2%
0.02%
+37.5%
Q4 2022$618,818
-11.5%
223,400
-18.2%
0.02%
-15.8%
Q3 2022$699,000
-31.5%
273,000
-3.7%
0.02%
-17.4%
Q2 2022$1,021,000
-27.1%
283,600
+25.8%
0.02%
-14.8%
Q1 2022$1,400,000
-50.2%
225,517
-43.5%
0.03%
-48.1%
Q4 2021$2,814,000
-6.0%
399,117
-7.0%
0.05%
-8.8%
Q3 2021$2,995,000
-16.2%
429,1170.0%0.06%
-10.9%
Q2 2021$3,575,000
+92.6%
429,117
+26.2%
0.06%
+82.9%
Q1 2021$1,856,000
+6.2%
339,917
-16.6%
0.04%
-5.4%
Q4 2020$1,748,000
+4.6%
407,517
-26.6%
0.04%
-2.6%
Q3 2020$1,671,000
-14.4%
555,017
-11.9%
0.04%
-2.6%
Q2 2020$1,953,000
+41.1%
630,017
+0.6%
0.04%
+21.9%
Q1 2020$1,384,000
-29.7%
626,217
-3.0%
0.03%
+23.1%
Q4 2019$1,969,000
-0.8%
645,6170.0%0.03%
-3.7%
Q3 2019$1,985,000
+83.3%
645,617
+19.3%
0.03%
+92.9%
Q2 2019$1,083,000
-58.4%
541,317
-10.5%
0.01%
-56.2%
Q1 2019$2,605,000
+28.1%
604,517
-5.5%
0.03%
+18.5%
Q4 2018$2,033,000
-37.5%
639,417
+3.3%
0.03%
-15.6%
Q3 2018$3,251,000
-21.1%
619,217
-19.6%
0.03%
-23.8%
Q2 2018$4,119,000
+7.0%
769,9170.0%0.04%
+2.4%
Q1 2018$3,850,000
+39.5%
769,917
-7.9%
0.04%
+36.7%
Q4 2017$2,759,000
-6.3%
835,917
+6.4%
0.03%
-11.8%
Q3 2017$2,946,000
+63.6%
785,617
+11.2%
0.03%
+54.5%
Q2 2017$1,801,000
+34.6%
706,217
+37.2%
0.02%
+37.5%
Q1 2017$1,338,000
+18.8%
514,717
+39.5%
0.02%
+6.7%
Q4 2016$1,126,000
+63.0%
369,017
+45.3%
0.02%
+50.0%
Q3 2016$691,000
-3.8%
254,017
+1.2%
0.01%
-9.1%
Q2 2016$718,000
-5.3%
251,1170.0%0.01%
-15.4%
Q1 2016$758,000
-13.0%
251,1170.0%0.01%
-18.8%
Q4 2015$871,000
+14.6%
251,117
+24.9%
0.02%0.0%
Q3 2015$760,000
-33.8%
201,117
-0.2%
0.02%
-30.4%
Q2 2015$1,148,000
-2.1%
201,4670.0%0.02%
-4.2%
Q1 2015$1,173,000
+2.9%
201,467
+0.2%
0.02%
-7.7%
Q4 2014$1,140,000
+38.5%
201,1170.0%0.03%
+23.8%
Q3 2014$823,000
-10.1%
201,1170.0%0.02%
-12.5%
Q2 2014$915,000
-4.0%
201,1170.0%0.02%
-11.1%
Q1 2014$953,000
+0.8%
201,1170.0%0.03%
-6.9%
Q4 2013$945,000
-10.7%
201,1170.0%0.03%
-19.4%
Q3 2013$1,058,000
+12.7%
201,117
+0.7%
0.04%
-5.3%
Q2 2013$939,000199,8170.04%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q2 2018
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders